Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Passing the Test: A Model-based analysis of safe school-reopening strategies

Alyssa Bilinski, Joshua A. Salomon, John Giardina, Andrea Ciaranello, Meagan C. Fitzpatrick
doi: https://doi.org/10.1101/2021.01.27.21250388
Alyssa Bilinski
1Interfaculty Initiative in Health Policy, Harvard Graduate School of Arts and Sciences
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: abilinski{at}g.harvard.edu
Joshua A. Salomon
2Center for Health Policy & Center for Primary Care and Outcomes Research, Stanford University School of Medicine
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Giardina
1Interfaculty Initiative in Health Policy, Harvard Graduate School of Arts and Sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Ciaranello
3Medical Practice Evaluation Center and Division of Infectious Disease, Massachusetts General Hospital, Harvard Medical School
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meagan C. Fitzpatrick
4Center for Vaccine Development and Global Health, University of Maryland School of Medicine
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The COVID-19 pandemic has induced historic educational disruptions. In December 2020, at least two-thirds of US public school students were not attending full-time in-person education. The Biden Administration has expressed that reopening schools is a priority.

Objective To compare risks of SARS-COV-2 transmission in schools across different school-based prevention strategies and levels of community transmission.

Design We developed an agent-based network model to simulate transmission in elementary and high school communities, including home, school, and inter-household interactions.

Setting We parameterized school structure based on average US classrooms, with elementary schools of 638 students and high schools of 1,451 students. We varied daily community incidence from 1 to 100 cases per 100,000 population.

Patients (or Participants) We simulated students, faculty/staff, and adult household members.

Interventions We evaluated isolation of symptomatic individuals, quarantine of an infected individual’s contacts, reduced class sizes, alternative schedules, staff vaccination, and weekly asymptomatic screening.

Measurements We projected transmission among students, staff and families during one month following introduction of a single infection into a school. We also calculated the number of infections expected for a typical 8-week quarter, contingent on community incidence rate.

Results School transmission risk varies according to student age and community incidence and is substantially reduced with effective, consistent mitigation measures. Nevertheless, when transmission occurs, it may be difficult to detect without regular, frequent testing due to the subclinical nature of most infections in children. Teacher vaccination can reduce transmission to staff, while asymptomatic screening both improves understanding of local circumstances and reduces transmission, facilitating five-day schedules at full classroom capacity.

Limitations There is uncertainty about susceptibility and infectiousness of children and low precision regarding the effectiveness of specific prevention measures, particularly with emergence of new variants.

Conclusion With controlled community transmission and moderate school-based prevention measures, elementary schools can open with few in-school transmissions, while high schools require more intensive mitigation. Asymptomatic screening should be a key component of school reopenings, allowing reopening at higher community incidence while still minimizing transmission risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors were supported by the Centers for Disease Control and Prevention though the Council of State and Territorial Epidemiologists (NU38OT000297-02; AB, JAS), the National Institute of Allergy and Infectious Diseases (R37AI058736-16S1; ALC and K01AI141576; MCF), the National Institute on Drug Abuse (3R37DA01561217S1; JAS). The papers' contents are solely the responsibility of the authors and do not necessarily represent the official views of the funders

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • (meagan.fitzpatrick{at}som.umaryland.edu)

Data Availability

Model code is available at https://github.com/abilinski/BackToSchool2.

https://github.com/abilinski/BackToSchool2

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted January 29, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Passing the Test: A Model-based analysis of safe school-reopening strategies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Passing the Test: A Model-based analysis of safe school-reopening strategies
Alyssa Bilinski, Joshua A. Salomon, John Giardina, Andrea Ciaranello, Meagan C. Fitzpatrick
medRxiv 2021.01.27.21250388; doi: https://doi.org/10.1101/2021.01.27.21250388
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Passing the Test: A Model-based analysis of safe school-reopening strategies
Alyssa Bilinski, Joshua A. Salomon, John Giardina, Andrea Ciaranello, Meagan C. Fitzpatrick
medRxiv 2021.01.27.21250388; doi: https://doi.org/10.1101/2021.01.27.21250388

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)